drugset / Trial / NCT02630095
The Effect of Anticoagulation in Cirrhotic Patients With Portal Vein Thrombosis：A Multicenter RCT
Phase 4
Unknown
96 enrolled
Shanghai Zhongshan Hospital
Eastern Hepatobiliary Surgery Hospital · collabShanghai General Hospital, Shanghai Jiao Tong University School of Medicine · collabShanghai Public Health Clinical Center · collabShanghai Pudong New Area Gongli Hospital · collabShuGuang Hospital · collabXinhua Hospital, Shanghai Jiao Tong University School of Medicine · collab
RandomizedParallel-groupOpen-labelTreatment
Summary
The purpose of this study is to determine the effect and safety of anticoagulation after endoscopic therapy in cirrhotic patients with portal vein thrombosis and to explore its effect on long-term rebleeding rate and mortality.
Timeline
- Start
- 2015-12
- Primary completion
- 2018-09
- Completion
- 2018-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Nadroparin Calcium | Other / unclassified | 4100 iu | Subcutaneous |
| Subject | Warfarin | Small molecule | 2.5 mg | — |